Microbiotica is a clinical-stage biopharmaceutical company focused on developing precision microbiome medicines. It aims to treat conditions like ulcerative colitis by promoting gut health through targeted bacterial therapies.
Founded
2016
Total Funding
$100M+
Total Rounds
2
First Raise
Mar 7, 2022
Latest Raise
Oct 16, 2026
New funding rounds in your inbox every week · No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/16/2026 | |||
1 more funding round available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week · Free